×

ACM Global Central Lab Announces Todd Meyers as Vice President of Sales and Marketing

Seasoned Executive Brings Fresh Perspective on Growth Strategies for Global Central Lab

Rochester, NY, June 7, 2011 - ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, is pleased to announce that Todd Meyers has joined the executive management team as vice president of sales and marketing and will be responsible for global business development efforts. Meyers brings to ACM a wealth of experience in global sales management, strategic marketing, proposal development and market research that has been gained through a highly successful career in the pharmaceutical and pharmaceutical support services industries.

Prior to joining ACM, Meyers was an executive at i3 Global, a pharmaceutical services company, where he was head of Business Development and Therapeutic Planning for the Clinical Drug Development Services Division. Prior to that, he was senior vice president, Sales, Marketing and Consulting for the Zitter Group, and executive director, Business Development for Covance's North America Clinical and Periapproval Services business. Meyers also spent several years at Innovex, a division of Quintiles, where he served in roles of increasing strategic responsibility, including general manager, vice president of Operations and Sales for the Primary Care and Specialty Contract Sales Division.

“We are delighted to have Todd join us at ACM,” said Angela J. Panzarella, president of ACM Global Central Lab. “He comes to ACM with extensive leadership experience and a track record of success in areas that are critical to the continued growth and success of our business.”

ACM will be on hand to discuss the latest trends in clinical research lab testing at the 7th Annual Pharmaceutical Conference Management Group (PCMG), June 8-10, in Dubrovnik, Croatia, as sponsors of the event.


About ACM Global Central Laboratory
ACM Global Central Laboratory offers a flexible approach and a focus on precision to keep clinical research studies on schedule. ACM Global’s operations extend to more than 60 countries with all tests conducted and managed from central lab facilities with seamless data management providing a single database. The organization performs 13 million tests each year, featuring more than 1,500 individual tests spanning all medical disciplines, including pathology, microbiology, flow cytometry and pharmacogenomics. Combining comprehensive safety, efficacy and pathology testing from a single lab ensures clients receive consistent, analyzable test results with faster and cleaner reporting. For more information, visit www.acmgloballab.com.
 

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement